Fusion Scans
Back

CYTK

NASDAQ
Cytokinetics, Inc. · Healthcare · Biotechnology
Loading quote…

Highlights

Market Cap
$10.30B
PE Ratio
EV to Ebitda
Earnings Yield
-10.21%
Revenue (TTM)
$88.0M
Net Income (TTM)
$-785.0M
Revenue (Annual YoY Growth)
376.56%
Revenue (Quarterly YoY Growth)
4.89%
Profit Margin
-891.60%
Return on Equity
Debt to Equity Ratio
-1.9469
Dividend Yield
0.00%

All fundamentals

Core10 fields
Market Cap$10.30B
Revenue TTM$88.0M
Shares Outstanding123.2M
Float100934663
Float Short11.98%
Days To Cover8.2254683802
Short Interest14806324.0
Insider Ownership4.86%
Relative Strength79.9
GARP4774
Growth Estimates15 fields
Revenue Growth (Annual)376.56%
Revenue Growth (Quarterly YoY)4.89%
Operating Revenue Growth (Annual)-0.072177
Operating Revenue Growth (Quarterly YoY)-0.359865
3-Year Revenue Growth-2.36%
5-Year Revenue Growth9.54%
EPS Growth (Annual)-24.14%
EPS Growth (Quarterly YoY)-17.65%
3-Year EPS Growth Rate0.00%
5-Year EPS Growth Rate0.00%
LT EPS Growth Estimates-32.76%
EBITDA Growth (Annual)-14.32%
EBITDA Growth (Quarterly YoY)-28.43%
CFO Growth (Annual)-28.83%
CFO Growth (Quarterly YoY)-117.56%
Operations28 fields
Revenue TTM$88.0M
Gross Margin TTM88.50%
Gross Margin (Quarterly)83.89%
R&D % of Revenue TTM461.05%
R&D Expenses TTM$405.9M
Operating Margin TTM-695.44%
Operating Margin (Quarterly)-1004.60%
Operating Expenses TTM$690.2M
Profit Margin TTM-891.60%
Profit Margin (Quarterly)-1030.87%
Net Income TTM$-785.0M
EPS TTM-6.5335
EPS (Quarterly)-1.4949
EBIT Margin TTM-695.44%
EBIT Margin (Quarterly)-1004.60%
EBITDA Margin TTM-683.94%
EBITDA Margin (Quarterly)-988.48%
EBITDA TTM$-602.1M
CFO % of Revenue TTM-579.30%
CFO % of Revenue (Quarterly)-803.44%
CFO TTM$-510.0M
Cash Margin-579.30%
Capex % of Revenue TTM28.18%
Capital Expenditures$24.8M
FCF % of Revenue TTM-607.48%
FCF % of Revenue (Quarterly)-835.23%
FCF TTM$-534.8M
Fundamental Score2
Efficiency5 fields
ROA-58.12%
ROIC-132.25%
CROCI-90.11%
Stock Comp % (Quarterly)171.82%
Stock Comp % TTM127.54%
Valuation12 fields
P/S Forward85.0169
PEG-0.4114
EV/EBITDA Forward-11.2798
EV/Revenues (TTM)94.0223
EV/Revenues Forward89.3214
EV/CFO-16.0992
EV/FCF (TTM)-15.4775
Price to Tangible Book29.2921
Earnings Yield-10.21%
FCF Yield-6.96%
Dividend Yield0.00%
Value Score1
Relative to Industry3 fields
Relative Gross Margin (Quarterly)1.0748
Relative P/S14.225
Relative Dividend Yield0
Liquidity15 fields
Cash Per Share7.2012
Current Ratio4.5293
Cash & ST Assets$885.3M
Total Debt$1.27B
Goodwill & Intangibles$0.00M
Total Assets$1.42B
Total Liabilities$2.08B
Shareholders Equity$-659.6M
Debt to Equity-1.9469
Debt to Assets90.15%
Interest Expense$103.9M
Times Interest Earned-5.8946
CFO to Debt (TTM)-0.5184
Debt to EBITDA (TTM)-1.6338
Goodwill % of Assets0.00%
Yields4 fields
Dividend Yield0.00%
Earnings Yield-10.21%
Buyback Yield-0.46%
Shareholder Yield-1.73%
Options Flow8 fields
Call Volume9322
Put Volume531
Put/Call Ratio0.056962025316455694
Call $ Volume5051829
Put $ Volume105581
Put/Call $ Ratio0.02089955934771347
Call OI105365
Put OI46754

News AI summary

Past 90 days of news, summarised by GPT

Upgrade to use
Click Generate to run a GPT analysis. Cached for 24h once generated.

Press release AI summary

Past 90 days of press releases, summarised by GPT

Upgrade to use
Click Generate to run a GPT analysis. Cached for 24h once generated.

Income statement AI analysis

Recent quarterly income statements with margin trends

Upgrade to use
Click Generate to run a GPT analysis. Cached for 24h once generated.

Balance sheet AI analysis

Recent quarterly balance sheets with leverage trends

Upgrade to use
Click Generate to run a GPT analysis. Cached for 24h once generated.

Cash flow AI analysis

Recent quarterly cash flow statements with FCF trends

Upgrade to use
Click Generate to run a GPT analysis. Cached for 24h once generated.